Skip to content

Euthymic Therapy: a Randomised Controlled Trial

Euthymic Therapy: a Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00003690
Enrollment
44
Registered
2012-04-02
Start date
2007-10-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33

Interventions

Group 1: Euthymic therapy, group intervention, 7 weekly sessions à 50 min Group 2: psychoeducation, group therapy, 7 weekly sessions à 50 min

Sponsors

Charité Campus Charité Mitte
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of depression (ICD-10: F32, F33) partialremission (HAMD-21 depression score of </= 9) or a reduction of depression severity by 50% (HAMD) from the peak during inpatient treatment. Psychiatric treatment as usual remained, and it was ensured that no change in medication occurred within two weeks prior to the start of the group intervention.

Exclusion criteria

Exclusion criteria: History of bipolar disorder, cyclothymia, schizophrenia, schizoaffective disorder, organic brain damage or substance abuse/dependence. Participation in a pharmaceutical study and ongoing individual psychotherapy were further exclusion criteria as well as borderline (ICD-10: F60.3) or antisocial personality disorders (ICD-10: F60.2).

Design outcomes

Primary

MeasureTime frame
Our project thus aimes to assess the effects of ET on reduction of depressive symptoms (HAMD-21, BDI), anhedonia (TAF) and a patient's health resources (MR FSF) in a randomized, controlled, parallel-group design. We expect ET to reduce depressive residual symptoms and anhedonia and improve self care as effectively as the validated reference treatment (psychoeducation). 3 measuring times: baseline, post intervention an follow-up (after 3 month). Following questionaires were used: •Hamilton Depression Scale (HAMD) •Tübinger-Anhedonie-Fragebogen (TAF) •Becks Depressions Inventar (BDI II) •Marburger Skalen zur Selbstfürsorge (MR FSF)

Secondary

MeasureTime frame
Additionally we expect an increase in following parameters: leisure activities (Checkliste der Freizeitaktivitäten, CFA), liefe-satisfaction (Lebenszufriedenheitsbogen, LZF), pleasure (Genussfragebogen, SFS), general state of health (Fragebogen zum allg. Gesundheitszustand), SF-36), self-efficacy (Fragebogen zum Selbstwirksamkeitserleben, SWE), locus of control (Fragebogen zur Erhebung von Kontrollüberzeugungen zu Krankheit und Gesundheit, KKG), sense of coherence (Marburger Skalen zum Kohärenzsinn, MR SOC). 3 measuring times: baseline, post intervention an follow-up (after 3 month).

Countries

Germany

Contacts

Public ContactJulia Kiermeir

Charité Campus Charité Mitte

julia.kiermeir@charite.de030450517203

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026